Status:
COMPLETED
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Lead Sponsor:
Alcon Research
Conditions:
Myopia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-...
Eligibility Criteria
Inclusion
- Participants must be between 18 and 65 years of age.
- Must wear daily wear soft contact lenses a minimum of 8 hours per day,7 days a week.
- Must be wearing a planned replacement soft lens in a 2 week or monthly replacement modality.
- Must be using either COMPLETE Multi-Purpose Solution (MPS) Easy Rub or ReNu MultiPlus brand solution for at least 30 continuous days prior to enrollment.
- Must be free of any contact lens-related symptoms with regard to comfort and vision throughout their wearing hours prior to enrollment, with the exception of end-of-day dryness not limiting all day wear.
- Must have best corrected distance visual acuity, with contact lenses, of 20/30 or better in each eye.
- Must be willing to maintain pre-enrollment systemic medication regimens during the study.
- Must be willing to not use any topical medications or rewetting drops during the 30 day clinical trial duration.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Has used any topical medication or rewetting drops for 7 days prior to enrollment.
- Achieves best visual correction by monovision.
- Has modified their systemic medications within 30 days prior to enrollment.
- Has switched brands of cosmetics during the 30 days prior to the study.
- Has a history of allergy to any study product ingredients.
- Is unwilling or unable to meet the study visit timeline.
- Has any active corneal, eyelid or other anterior segment inflammation or infection, which, in the opinion of the Investigator, would adversely affect successful contact lens wear.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00772707
Start Date
September 1 2008
End Date
October 1 2008
Last Update
September 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134